World Top 100 Biotechnology Companies List by Market Cap as of August 2026

Syneos Health is a Biopharmaceutical Solutions company. It having approximately 24,000 clinical and commercial minds with the ability to support customers in more than 110 countries. The headquarters is in USA.

Syneos Health was acquired by a consortium of private investment firm affiliates composed of Elliott Investment Management, Patient Square Capital, and Veritas Capital for $43.00 per share in cash in a transaction valued at approximately $7.1 billion, including outstanding debt. Definitive agreement related to the acquisition was made in May-2023.

Biotechnology company and gene editing company to control couple of human diseases like Cancer and couple of other diseases and it's headquarters is in Switzerland.

With CRISPR/Cas9, they aim to target the source of genetically-defined diseases and engineer the next generation of cellular therapies

MyoKardia is a Transformative Therapies company. It is applying a precision medicine approach to develop therapeutic candidates for patient populations with shared characteristics such as causal genetic mutations or disease subtypes. The headquarters is in USA.

Bristol Myers Squibb acquired MyoKardia for 13.1 Billion USD in Nov-2020.

Chongqing Zhifei Biological Products is Biotechnology company with nearly 3,000 employees, and assets of 13.6 billion yuan.

In 2019, it achieved operating income of 10.59 billion yuan.

Turning Point Therapeutics is a clinical-stage biopharmaceutical company designing and developing novel small molecule, targeted oncology therapies to address key limitations of existing therapies and improve the lives of patients. Headquarters is in USA.

Turning Point develops kinase inhibitors, a class of targeted cancer drugs, that are designed to bind to cancer cells with greater precision and affinity than existing therapies.

SK Biopharmaceuticals is a Biopharmaceutical company that develops new drugs in support of innovations in the medical field. The headquarters is in South Korea.

Acadia Pharmaceuticals is a Healthcare and Pharmaceutical company. The company is of food and drug administration for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis. Around 8 million people in the United States are living with dementia and studies suggest that approximately 30% of people with dementia, 2.4 million people, experience dementia-related hallucinations and delusion. The headquarters is in USA.